Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To test the efficacy of 14 day levofloxacin and bismuth-containing second-line therapy for resistant Helicobacter pylori infection, to compare with the classical quadruple therapy.
Epistemonikos ID: e100e703accb302460281874874690ee438505f5
First added on: May 11, 2024